Has David Baran, MD received payments from drug or device companies?

Yes. Drug and device makers reported $434,743 in general payments to David Baran, MD across 306 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Baran, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Baran, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Baran, MD

Advanced Heart Failure and Transplant Cardiology · Weston, FLNPI 1871594150

Payments from drug & device makers

$434,743in general payments, 2019–2025

Across 306 payments — averaging $1420.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$138K
Boehringer Ingelheim$73K
Astellas Pharma Global Development$58K
Transmedics, Inc.$48K
Livanova USA, Inc.$24K
Pfizer$16K
plus $79K from 33 others

$4,218in research payments, 2019–2025

Across 7 payments — averaging $602.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Xvivo Perfusion Inc.$3K
Transmedics, Inc.$843

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	108	$137,588
Boehringer Ingelheim	2	$73,253
Astellas Pharma Global Development	1	$58,000
Transmedics, Inc.	5	$47,647
Livanova USA, Inc.	29	$23,617
Pfizer	9	$15,606
Novartis	9	$11,928
Getinge USA Sales, LLC	11	$11,147
Boehringer Ingelheim Pharma GmbH & Co.kg	6	$7,257
Alnylam Pharmaceuticals Inc.	11	$6,747
Arrow International, Inc.	2	$6,289
Michigan Critical Care Consultants, Inc.	2	$5,425
Abiomed	31	$4,541
Impulse Dynamics (USA) Inc.	9	$3,698
Magenta Medical Inc	2	$3,550
AstraZeneca	5	$3,382
Maquet Cardiovascular L.L.C.	1	$3,300
Procyrion, Inc.	6	$2,686
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	3	$2,208
Datascope Corp.	6	$1,731
Xvivo Perfusion Inc.	1	$1,500
Edwards Lifesciences	4	$588
Eurofins Viracor, LLC	1	$518
Medtronic(2 entities)	6	$471
Cvrx, Inc.	4	$352
Biosense Webster, Inc.	9	$347
Boston Scientific	6	$252
Akcea Therapeutics, Inc.	2	$238
Endotronix, Inc.	1	$225
Cardiovascular Systems Inc.	1	$129
Scpharmaceuticals Inc.	1	$119
Sensible Medical Innovations Inc	1	$115
Cardiva Medical, Inc.	4	$92
Actelion Pharmaceuticals US, Inc.	2	$59
Shockwave Medical, Inc	1	$39
Bridgebio Pharma, Inc.	1	$33
Philips North America LLC	1	$30
Astellas Pharma US Inc	1	$24
Lexicon Pharmaceuticals, Inc.	1	$13

How this compares

$434,743 in reported general payments places this provider in the 90th percentile of 48 advanced heart failure and transplant cardiology providers in Florida.

See all advanced heart failure and transplant cardiology providers in Florida →

Medicare billing

Part B allowed, 2024

$134,180

Medicare patients

259

Services billed

1,175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other advanced heart failure and transplant cardiology in Weston

David SnipeliskyWeston$386K
Antonio Lewis CamargoWeston$7K
Omar Wever-PinzonMiami$1.2M
Stacy MandrasOrlando$959K
Kelly McCantsWinter Park$475K
Andrija VidicOrlando$449K
Naveen BellamOrlando$414K
Sandra ChaparroMiami$352K
Phillip HabibDelray Beach$340K
Waqas GhummanAtlantis$296K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →